These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 16513606)

  • 1. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis.
    Van Laere K; Casteels C; De Ceuninck L; Vanbilloen B; Maes A; Mortelmans L; Vandenberghe W; Verbruggen A; Dom R
    J Nucl Med; 2006 Mar; 47(3):384-92. PubMed ID: 16513606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease.
    Bosman T; Van Laere K; Santens P
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):16-24. PubMed ID: 12483405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Extrastriatal
    Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J
    J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
    [No Abstract]   [Full Text] [Related]  

  • 4. Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters.
    Van Laere K; Santens P; Bosman T; De Reuck J; Mortelmans L; Dierckx R
    J Nucl Med; 2004 Jun; 45(6):933-42. PubMed ID: 15181127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.
    Koch W; Radau PE; Hamann C; Tatsch K
    J Nucl Med; 2005 Jul; 46(7):1109-18. PubMed ID: 16000279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis of parkinsonian syndromes using dopamine transporter and perfusion SPECT.
    Takaya S; Sawamoto N; Okada T; Okubo G; Nishida S; Togashi K; Fukuyama H; Takahashi R
    Parkinsonism Relat Disord; 2018 Feb; 47():15-21. PubMed ID: 29157745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is iterative reconstruction an alternative to filtered backprojection in routine processing of dopamine transporter SPECT studies?
    Koch W; Hamann C; Welsch J; Pöpperl G; Radau PE; Tatsch K
    J Nucl Med; 2005 Nov; 46(11):1804-11. PubMed ID: 16269593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
    J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease.
    Swanson RL; Newberg AB; Acton PD; Siderowf A; Wintering N; Alavi A; Mozley PD; Plossl K; Udeshi M; Hurtig H
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):302-7. PubMed ID: 15791439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.
    Seppi K; Scherfler C; Donnemiller E; Virgolini I; Schocke MF; Goebel G; Mair KJ; Boesch S; Brenneis C; Wenning GK; Poewe W
    Arch Neurol; 2006 Aug; 63(8):1154-60. PubMed ID: 16908744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of Parkinson's disease-related network expression with ECD SPECT.
    Eckert T; Van Laere K; Tang C; Lewis DE; Edwards C; Santens P; Eidelberg D
    Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):496-501. PubMed ID: 17096095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy.
    Knudsen GM; Karlsborg M; Thomsen G; Krabbe K; Regeur L; Nygaard T; Videbaek C; Werdelin L
    Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1631-8. PubMed ID: 15583914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.
    Scherfler C; Seppi K; Donnemiller E; Goebel G; Brenneis C; Virgolini I; Wenning GK; Poewe W
    Brain; 2005 Jul; 128(Pt 7):1605-12. PubMed ID: 15817519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-aided diagnosis of Parkinson's disease based on [(123)I]FP-CIT SPECT binding potential images, using the voxels-as-features approach and support vector machines.
    Oliveira FP; Castelo-Branco M
    J Neural Eng; 2015 Apr; 12(2):026008. PubMed ID: 25710187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative simultaneous (99m)Tc-ECD/123I-FP-CIT SPECT in Parkinson's disease and multiple system atrophy.
    El Fakhri G; Habert MO; Maksud P; Kas A; Malek Z; Kijewski MF; Lacomblez L
    Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):87-92. PubMed ID: 16180033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.
    Kas A; Payoux P; Habert MO; Malek Z; Cointepas Y; El Fakhri G; Chaumet-Riffaud P; Itti E; Remy P
    J Nucl Med; 2007 Sep; 48(9):1459-67. PubMed ID: 17704252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study.
    Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
    Nucl Med Commun; 2006 Apr; 27(4):381-6. PubMed ID: 16531926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dopamine transporter imaging in routine clinical practice.
    Marshall V; Grosset D
    Mov Disord; 2003 Dec; 18(12):1415-23. PubMed ID: 14673877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Imaging of dopamine transporter with Tc99m-Trodat-SPECT in movement disorders].
    Kanyó B; Argyelán M; Dibó G; Szakonyi Z; Vécsei L; Fülöp F; Láncz A; Forgács P; Pávics L
    Ideggyogy Sz; 2003 Jul; 56(7-8):231-40. PubMed ID: 12971118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.